10-Q: Horizon Space Acquisition II Corp. Q1 2026 Update

Sentiment:

Quarterly Report


Horizon Space Acquisition II Corp. reports a net loss for Q1 2026, with significant redemptions and ongoing efforts to complete a business combination.

Delay expectedThe company has extended its deadline to consummate its initial business combination multiple times, with the current latest possible date being February 18, 2027.The company has issued promissory notes to facilitate these extensions, indicating a need for additional time and resources to find a suitable target.
Capital raiseThe company entered into subscription agreements with certain investors for a private placement (PIPE Financing) of 780,000 units at $10.00 per unit for aggregate gross proceeds of $7,800,000.The Sponsor and William Wang have provided funds through promissory notes, which can be converted into private units, indicating potential future capital infusion.The company may need to obtain additional financing either to complete its Business Combination or because it becomes obligated to redeem a significant number of public shares.
Worse than expectedThe company reported a net loss for the quarter, compared to a net income in the prior year's comparable period.The Trust Account balance has significantly decreased due to substantial share redemptions.The company's working capital position has deteriorated, leading to substantial doubt about its ability to continue as a going concern.

Summary

  • Horizon Space Acquisition II Corp. (HSPT) reported a net loss of $29,122 for the three months ended March 31, 2026.
  • The company's cash balance was $9,586 as of March 31, 2026, with a working capital deficit of $1,784,554.
  • Significant redemptions occurred, with $34,221,276 withdrawn from the Trust Account for 3,219,311 ordinary shares redeemed on March 17, 2026.
  • The company continues to seek a business combination and has extended its deadline to February 18, 2027, with further extensions possible.
  • The Sponsor and William Wang have provided additional funding through promissory notes to facilitate extensions.
  • The company has substantial doubt about its ability to continue as a going concern, with plans to address this through working capital loans.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as negative due to the net loss, substantial redemptions, and the acknowledgment of substantial doubt regarding the company's ability to continue as a going concern, despite efforts to extend the business combination deadline.

Positives

  • The company secured extensions to its business combination deadline, now extending to February 18, 2027, with further monthly extensions possible.
  • The Sponsor and William Wang have provided additional funding via promissory notes to support these extensions.
  • The company has a clear path for potential conversion of these notes into private units upon a business combination.
  • Interest and dividend income from the Trust Account was $588,076 for the quarter.

Negatives

  • The company reported a net loss of $29,122 for the quarter ended March 31, 2026.
  • The company has a working capital deficit of $1,784,554 as of March 31, 2026.
  • A substantial number of ordinary shares (3,219,311) were redeemed, totaling $34,221,276, significantly reducing the Trust Account balance.
  • The company's ability to continue as a going concern is subject to substantial doubt.
  • The company has incurred significant professional costs related to its public company status and pursuit of a business combination.

Risks

  • The company may not be able to complete a Business Combination by the extended deadline of February 18, 2027, which could lead to liquidation.
  • The proceeds deposited in the Trust Account could be subject to the claims of creditors, potentially having priority over public shareholders.
  • The rights issued in connection with the IPO may expire worthless if a Business Combination is not completed.
  • The company's ability to raise additional financing to complete a Business Combination or meet redemption obligations is uncertain.
  • Global conflicts (Russia/Ukraine, Hamas/Israel) could adversely affect the ability to consummate a Business Combination or the operations of a target business.

Future Outlook

The company is actively pursuing a business combination and has extended its deadline to February 18, 2027, with potential for further monthly extensions. Management has identified substantial doubt about the company's ability to continue as a going concern, with plans to address this through working capital loans. The company expects to continue incurring significant costs related to its public company status and acquisition efforts.

Management Comments

  • Management has determined that conditions raise substantial doubt about the Company's ability to continue as a going concern.
  • Management's plan to address going concern uncertainty involves working capital loans from the Sponsor or its affiliates.
  • If the Company is unable to complete a business combination by the Combination Period, the board of directors would proceed to commence a voluntary liquidation.

Industry Context

StockSavvy.ai notes that Horizon Space Acquisition II Corp. is a Special Purpose Acquisition Company (SPAC), a common vehicle for taking private companies public. The current filing reflects the typical challenges faced by SPACs, including the pressure to complete a business combination within a set timeframe and the significant impact of shareholder redemptions on available capital.

Comparison to Industry Standards

  • The redemption rate of 3,219,311 shares for $34,221,276 is a significant portion of the initial IPO units, which is a common concern for SPACs as high redemptions reduce the capital available for a business combination.
  • The extension of the combination deadline is a standard practice for SPACs that require more time to identify and negotiate a suitable target, often involving additional funding from the sponsor or related parties.
  • The net loss of $29,122 for the quarter is typical for SPACs in their pre-business combination phase, as they primarily incur operating and professional expenses without generating revenue.

Legal Proceedings

  • The company is not currently a party to any material litigation or other legal proceedings.

Related Party Transactions

  • The Sponsor, Horizon Space Acquisition II Sponsor Corp., has provided loans and advances to the company.
  • William Wang, CEO of SL Bio, has provided funds through promissory notes for extension fees.
  • The Sponsor has agreed to waive redemption rights for its Private Placement shares under certain conditions.
  • Founder Shares were issued to the Sponsor and subsequently transferred to directors and officers.
  • An affiliate of the Sponsor provides administrative support services for a monthly fee, though this fee was waived for a period.

Stakeholder Impact

  • Public shareholders face the risk of their investment being redeemed if a business combination is not completed, or receiving shares in a potentially less valuable combined entity.
  • The Sponsor and management are incentivized to complete a business combination to realize value from their investments and founder shares, but also face risks if the company liquidates.
  • Creditors could have claims on Trust Account funds, potentially impacting public shareholder returns.
  • Employees of a potential target company could face uncertainty regarding their roles and the future of the business post-combination.

Next Steps

  • Continue efforts to identify and consummate a business combination before the extended deadline.
  • Manage ongoing operational and professional expenses.
  • Potentially seek additional financing if required for the business combination or to meet redemption obligations.
  • If a business combination is not completed by the deadline, the company will proceed with voluntary liquidation.

Key Dates

DateDescription
2023-03-21Company incorporated in the Cayman Islands.
2024-07-01Independent Director Member
2024-07-26Sponsor acquired Founder Shares and surrendered one ordinary share.
2024-08-02Sponsor transferred Founder Shares to independent director nominees and CFO.
2024-11-01Underwriters Agreement Member
2024-11-18Initial Public Offering (IPO) closing date; underwriting commissions paid.
2024-11-19Underwriter notified of exercise of over-allotment option.
2024-11-21Over-allotment option units sold; additional private units sold; additional representative shares issued.
2025-05-09Company entered into a business combination agreement with SL Science Holding Limited (PubCo), CW Mega Limited, WW Century Limited, and SL Bio Ltd.
2025-07-02Promissory Note Agreement related party.
2025-07-05Company issued unsecured promissory notes to its Sponsor for working capital.
2025-11-17Extension fee deposited into Trust Account, extending deadline to February 18, 2026.
2025-12-31Balance sheet date for audited financial statements.
2026-01-01Ordinary shares subject to redemption and business combination EGM period.
2026-01-13Form F-4 registration statement declared effective; definitive proxy statement filed.
2026-02-01Ordinary shares subject to redemption period.
2026-02-12Business Combination EGM; ordinary shares submitted for redemption.
2026-02-13Extraordinary General Meeting (EGM) held; Charter Amendment approved; Business Combination EGM held.
2026-02-18Company has until this date to complete its initial business combination; promissory note issued to William Wang.
2026-03-17Ordinary shares redeemed for $34,221,276.
2026-03-24PubCo entered into subscription agreements for PIPE Financing.
2026-03-31Quarterly period end date.
2026-04-08Annual report on Form 10-K for the fiscal year ended December 31, 2025 filed.
2026-05-01Business Combination Agreement date.
2026-05-09Company entered into a Business Combination Agreement.
2026-05-14Extension deposit made by William Wang.
2026-05-18Company issued a Working Capital Note to the Sponsor; Promissory Note issued to William Wang.
2026-06-18Extended deadline to consummate initial business combination.
2027-02-18Latest possible extended deadline to consummate initial business combination.

Recommendation

hold

Keywords

Horizon Space Acquisition II Corp., SPAC, 10-Q, Quarterly Report, Business Combination, Trust Account, Redemption, Sponsor, Promissory Note, Going Concern

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.